Here, we report the use of an alkyne‐functionalized amidine, PhCN (Dipp) N (Dipp) C≡CSiMe 3 (1) (Dipp = 2, 6‐ i Pr 2 C 6 H 3), to access a range of Ge (IV), Ge (II/IV), Ge (II), and Ge (I) compounds based on an anionic dicarbene (ADC) framework (ADC = PhCN (Dipp) C 2). The mixed‐valent Ge (II/IV) complex (ADC) GeCl 3 GeCl 2 (4) is obtained by partial reduction of (ADC) GeCl 3 GeCl 4 (3). Treatment of 1 with 3 affords the Ge (IV) chloride (ADC) GeCl 3 2 (5), which can be sequentially reduced with KC 8 to give the known Ge (II) and Ge (I) species (ADC) GeCl 2 (7) and (ADC) Ge 2 (8), respectively. The 1, 4‐digermabenzene‐1, 4‐diide (8) is a singlet diradical that cleaves dihydrogen at room temperature to form the Ge (II) hydride (ADC) GeH 2 (9) ; under vacuum, 9 regenerates 8. Compound 8 reacts with azobenzene and diphenylacetylene to yield the corresponding 4+2‐cycloaddition products, (ADC) GeEPh 2 10 (E = N) and 11 (E = C), respectively. Treatment of 8 with TEMPO (2, 2, 6, 6‐tetramethylpiperidinyloxyl) produces the radical coupling product, the bis (TEMPO‐germylene) (ADC) GeTEMPO 2 (13). All compounds were characterized by spectroscopic methods, and their molecular structures, including that of 9, unknown previously, were confirmed by single‐crystal X‐ray diffraction.
Ebeler et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: